NON-CERULOPLASMIN BOUND COPPER LEVEL MONITORING

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20240382435A1
SERIAL NO

18288322

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the treatment and/or monitoring of subjects suffering from, or susceptible to, Wilson's Disease, and involves measuring the serum non-ceruloplasmin (NCC) level in a subject and determining whether the serum NCC level is within a specified range. Treatment regimes can be adjusted if appropriate to control the subject's serum NCC level to be within the desired range.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORPHALAN S A226 BOULEVARD VOLTAIRE 75011 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Amin, Naseem London Greater London, GB 7 0
Kamlin, Omar 75011 Paris, FR 1 0
Morley, Timothy James Harrogate Yorkshire, GB 8 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation